Tender detail

Biologics rebate agreements 2026 – Ranibizumab (15)

Summary

Techniker Krankenkasse (TK) seeks to conclude rebate agreements with suitable pharmaceutical companies for the active ingredient ranibizumab. The agreements use uniform terms, involve no individual negotiations and do not grant exclusivity. The contract period starts on 1 July 2026 and ends no later than 30 June 2027, with a maximum duration of 12 months.

Reference number
b1ec1b5b-6006-4a5c-b7be-4a584748507a
Buyer
Country
Germany (DEU)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2027-06-30
Status
Open
Contract subject
Supplies
Estimated value
Not published
Source
DEU_BKMS

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.